Sildenafil Medreg

Quick links

Choose a section

Quick links to important sections

Advertisements
Advertisements

Overview of Sildenafil Medreg

Property Description
Active ingredient Sildenafil (as citrate salt)
Form Oral, film-coated tablet
Pharmacological class Selective Phosphodiesterase Type 5 (PDE5) Inhibitor
Primary action Enhanced localized blood flow through vasodilation
Origin Synthetic compound

What Type of Medicine is Sildenafil Medreg?

Sildenafil Medreg is a specific pharmaceutical preparation supplied as an oral, film-coated tablet, containing the single active ingredient Sildenafil. It is officially classified as a Selective Phosphodiesterase Type 5 (PDE5) Inhibitor, identifying it as a highly targeted medicine. This classification identifies the drug's specialized role in modulating specific enzymatic activity within the body's vascular network. Sildenafil Medreg is recognized as a prescription-only medicine, underscoring its intended use under professional medical guidance.


Composition, Form, and Origin: Is Sildenafil Synthetic?

The core component, sildenafil, is a synthetic chemical compound, not derived from plant or natural sources, categorized chemically as a pyrazolopyrimidinone derivative. Sildenafil Medreg is a single-ingredient product, typically formulated as a tablet that contains the active substance (often the citrate salt) alongside inactive ingredients. This consistent and standardized nature of the synthetic compound ensures chemical purity and predictable pharmacological characteristics in every dose. The drug is manufactured to pharmaceutical standards, ensuring reliable systemic effect upon oral administration.


What is the General Purpose of Sildenafil Medreg?

The general purpose of the medicine is to achieve enhanced blood flow by acting directly on a specific enzyme that regulates blood vessel tone. The mechanism involves the inhibition of the PDE5 enzyme, which prevents the rapid breakdown of a key natural signaling molecule in the blood vessel walls. By preserving this molecule, the drug promotes the relaxation of smooth muscles within certain blood vessels, leading to vasodilation (vessel widening). This facilitated blood flow is the fundamental physiological effect that the drug is designed to provide, assisting the body in maintaining necessary localized circulatory dynamics.

Regulatory References

  1. SILDENAFIL tablets, for oral use. Initial U.S. Approval: 1998 - DailyMed
  2. MedlinePlus Drug Information on Sildenafil
  3. Mechanism of Action - Sildenafil (StatPearls - NCBI/NIH)
  4. Systemic Vasodilatory Effects - Sildenafil (StatPearls - NCBI/NIH)
Advertisements

What side effects are possible with Sildenafil Medreg?

Possible side effects and safety information

The safety profile of Sildenafil Medreg, as documented by official regulatory sources, is structured to classify and communicate potential adverse reactions and usage constraints. The most frequently reported effects are generally related to the medicine's vasodilatory properties.


Frequency-Classified Adverse Reactions

Side effects are categorized by frequency based on clinical data and post-marketing surveillance:

  • Very Common (ge 1 in 10 patients): Headache.
  • Common (ge 1 in 100 patients and <1 in 10 patients): Flushing, Dyspepsia, Abnormal Vision (e.g., color tinge, blurred vision), Nasal Congestion, and Dizziness. These effects are typically mild and transient.

Adverse reactions are formally grouped by System-Organ-Class, including the Vascular, Nervous System, Gastrointestinal, and Eye Disorders.


Serious Adverse Reactions and Restrictions

Regulatory documents highlight several serious adverse reactions regardless of their rarity. These include Priapism (a prolonged erection lasting over four hours), Non-arteritic Anterior Ischemic Optic Neuropathy (NAION), and sudden decrease or loss of hearing. Serious cardiovascular events, such as myocardial infarction or stroke, have been reported in temporal association, particularly during or shortly after sexual activity.

Safety labeling specifies absolute restrictions on use. Sildenafil Medreg is contraindicated with concomitant use of any form of organic nitrates or riociguat, due to the risk of severe hypotension. Use is also restricted in patients with severe hepatic impairment, severe hypotension (<90/50 mmHg), a recent history of stroke or myocardial infarction, or previous vision loss due to NAION.


Population-Specific Safety Considerations

Official labeling contains specific notes for defined patient groups. Use is not recommended in patients with known hereditary degenerative retinal disorders like Retinitis Pigmentosa. Caution is advised in patients with conditions predisposing them to priapism (e.g., sickle cell anemia). Use in pediatric patients for Pulmonary Arterial Hypertension is generally not recommended due to safety concerns documented by regulatory bodies.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile describes overdose as an increase in the frequency and severity of known dose-related adverse reactions. Exposure above the maximum dose is documented to result in exaggerated effects, including pronounced headache, flushing, and visual disturbances (e.g., blurred vision).

Severe outcomes involve the risk of symptomatic hypotension (severe drop in blood pressure) and syncope (fainting) due to excessive vasodilation. The regulatory labeling notes effects on the Cardiovascular, Genitourinary, Ocular, and Auditory systems, with specific acute risks in each.

Overdose effects may be more pronounced in patients with severe hepatic or renal impairment, as official documentation confirms the slower clearance of the compound from the body in these populations.

Management is required to be symptomatic and supportive. The official labeling explicitly states that no specific antidote is known. Furthermore, regulatory information notes that renal dialysis is not expected to accelerate clearance significantly due to the drug's volume of distribution.


When Immediate Medical Help is Required (Label-Derived Phrasing):

  • Seek immediate medical assistance if an erection persists for longer than 4 hours.
  • Seek immediate medical attention for a sudden loss of vision.
  • Seek prompt medical attention in the event of sudden decrease or loss of hearing.
Advertisements

Therapeutic Uses of Sildenafil Medreg

What Sildenafil Medreg Treats

Sildenafil Medreg is a pharmacological treatment primarily indicated for adult men experiencing erectile dysfunction, a condition characterized by the persistent inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.

Mechanism of Action

The active ingredient, sildenafil, belongs to a class of medications known as phosphodiesterase type 5 (PDE5) inhibitors. It works by aiding the relaxation of blood vessels in the penis, which facilitates increased blood flow into the erectile tissues during sexual stimulation. This process supports the natural physiological response required to achieve an erection.

Main Uses and Applications

The primary application of this medication is the management of impotence. It is important to note that Sildenafil Medreg is not an aphrodisiac; it does not increase sexual desire or arousal. Its function is strictly physiological, requiring the presence of sexual stimulation to be effective.

Benefits for Patient Quality of Life

By addressing the physical symptoms of erectile dysfunction, Sildenafil Medreg may provide several therapeutic benefits:

  • Restoration of Erectile Function: It assists in achieving a natural response to sexual stimuli.
  • Psychological Impact: Improved physical performance can lead to a reduction in the anxiety and stress often associated with sexual dysfunction.
  • Relational Stability: Consistent management of erectile difficulties can contribute to improved confidence and satisfaction within personal relationships.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Sildenafil is indicated for use in adult men for erectile dysfunction and in adults and certain pediatric patients for Pulmonary Arterial Hypertension (PAH).


Official Contraindications

Use of Sildenafil is strictly contraindicated in several specific populations, primarily due to the risk of severe, life-threatening hypotension or unstudied safety profiles. These include patients:

  • Taking any form of organic nitrates (such as nitroglycerin) or nitric oxide donors.
  • Taking guanylate cyclase (GC) stimulators (e.g., riociguat).
  • For whom sexual activity is inadvisable due to severe cardiovascular conditions (e.g., unstable angina or severe cardiac failure).
  • Who have experienced loss of vision in one eye due to Non-Arteritic Anterior Ischaemic Optic Neuropathy (NAION).
  • With known hypersensitivity to the active substance or any excipients.
  • With severe hepatic impairment, hypotension (blood pressure below 90/50 mmHg), a recent history of stroke or myocardial infarction, or known hereditary degenerative retinal disorders (e.g., retinitis pigmentosa).

Use Requiring Special Consideration

Lower starting doses (25 mg) are typically recommended for patients aged 65 years and older, those with severe renal impairment (creatinine clearance less than 30 mL/min), and patients with hepatic impairment. Use requires caution in patients with anatomical deformation of the penis or conditions predisposing to priapism (e.g., sickle cell anemia). It is not indicated for use by women for the treatment of erectile dysfunction.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Sildenafil Medreg (sildenafil) can interact with several other medicines, potentially increasing the risk of side effects, reducing the effectiveness of one or both drugs, or causing a severe drop in blood pressure. It is crucial to inform your doctor or pharmacist about all prescription, over-the-counter, and herbal medicines you are currently taking.

Contraindicated Combinations

Sildenafil must not be taken if you are using medicines known as nitrates (e.g., nitroglycerin, isosorbide dinitrate) in any form (tablet, patch, spray, or ointment). This combination can cause a dangerous and potentially fatal decrease in blood pressure. Similarly, concomitant use with guanylate cyclase stimulators (e.g., riociguat) is contraindicated due to the risk of severe hypotension.

Other Significant Interactions

Medicine Category Examples of Affected Medicines Potential Effect
Alpha-blockers Doxazosin, Tamsulosin Increased risk of low blood pressure (hypotension).
HIV Protease Inhibitors Ritonavir, Saquinavir Significantly increases sildenafil levels, requiring a lower Sildenafil Medreg dose.
Certain Antifungals/Antibiotics Ketoconazole, Erythromycin Increases sildenafil exposure, potentially increasing side effects.

Using Sildenafil Medreg with other treatments for erectile dysfunction is not recommended as the safety of these combinations has not been adequately studied.

Advertisements

Mechanism of Action

Selective Inhibition of the PDE5 Enzyme

Sildenafil is classified as a highly selective Phosphodiesterase Type 5 (PDE5) inhibitor. Its primary role is to block the PDE5 enzyme, which is responsible for breaking down the cellular messenger cyclic Guanosine Monophosphate (cGMP). By inhibiting this enzyme, the drug preserves and sustains higher concentrations of cGMP within specific tissues.


Modulation of the NO-cGMP Pathway

This molecular action operates within the Nitric Oxide (NO)-cGMP pathway. The drug requires the natural, physiological release of Nitric Oxide to initiate the production of cGMP. Sildenafil acts as a pathway modulator, sustaining the effect of this natural signal by preventing the rapid disposal of cGMP, thereby leading to the expression of the resulting physiological response.


Resulting Vascular Smooth Muscle Relaxation

The sustained elevation of cGMP directly causes the relaxation of vascular smooth muscle cells. This leads to vasodilation (vessel widening) and a consequential increase in localized blood flow in the target tissues. This modulation of local hemodynamics and muscle tone constitutes the physiological change produced by the mechanism.

Advertisements

Dosage and Administration Information

Sildenafil Medreg is an oral, film-coated tablet intended for administration via the mouth, although the active ingredient, sildenafil, is also approved for use as an intravenous injection or oral suspension in specific clinical contexts like Pulmonary Arterial Hypertension (PAH).

Official Dosing Regimens

The medicine is used under two distinct, official dosing protocols depending on the specific indication:

Indication Standard Regimen Frequency and Timing Population Adjustments
Erectile Dysfunction (ED) Recommended starting dose is 50 mg. Dose range: 25 mg to 100 mg. Taken as needed, approximately one hour before activity (30 minutes to 4 hours prior). Maximum frequency is once per day. A 25 mg starting dose should be considered for patients aged 65 years or older, or those with severe renal or hepatic impairment.
Pulmonary Arterial Hypertension (PAH) Standard dose is 20 mg three times a day (TID). Dose may be titrated up to a maximum of 80 mg TID. Taken on a scheduled basis three times a day, typically 4 to 8 hours apart, for long-term maintenance. Pediatric dosing (for PAH) is weight-dependent.

General Administration Instructions

Sildenafil Medreg may be taken with or without food; however, consuming it with a high-fat meal may delay the onset of its effects. If a dose is missed during the scheduled PAH regimen, the patient should take the missed dose as soon as it's remembered, unless it is nearly time for the next dose, in which case the missed dose should be skipped—do not double the dose. These instructions define the standardized use of the medicine.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence for Sildenafil

Clinical evidence for sildenafil primarily focuses on its two approved indications: erectile dysfunction (ED) and pulmonary arterial hypertension (PAH). Decades of research, including numerous large-scale, randomized, placebo-controlled trials, have established the therapeutic profile of this phosphodiesterase type 5 (PDE5) inhibitor.


Evidence in Erectile Dysfunction (ED)

Meta-analyses of clinical trials consistently show that sildenafil is associated with a significantly improved ability to attain and maintain an erection sufficient for sexual intercourse, compared to placebo. In studies involving men with ED of various origins (including organic, psychogenic, and mixed), response rates indicating improved erections ranged widely, often showing successful intercourse in over 50% of attempts compared to less than 25% for placebo. This effect has been documented across broad patient populations, including those with comorbidities such as diabetes mellitus and after radical prostatectomy, although effectiveness may be reduced in these more challenging patient groups. Long-term studies, some extending up to three years, indicate that the effectiveness is generally maintained, with high rates of patient satisfaction reported among those who continue treatment.


Evidence in Pulmonary Arterial Hypertension (PAH)

For the treatment of PAH (where sildenafil is often marketed under a different brand name), clinical trials demonstrate that the medication is associated with improved exercise capacity and delayed clinical worsening in adult patients. Specifically, evidence from randomized trials shows a statistically significant improvement in the Six-Minute Walk Distance (6MWD)—a standard measure of functional capacity—compared to placebo. Recent studies have focused on dose optimization in PAH, suggesting that certain higher doses may lead to greater improvements in functional capacity and event-free survival compared to lower doses, reinforcing the standard therapeutic approach for this condition. Sildenafil’s use in pediatric PAH patients is also supported by evidence, although careful risk-benefit consideration is required.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Sildenafil Medreg (FAQ)


Q: What is the expected duration of the effects of Sildenafil Medreg?

According to the official product information, Sildenafil is eliminated from the body with a half-life of approximately 3 to 5 hours. Based on clinical studies, the therapeutic response is generally observed for several hours, with effects that may last up to 4 hours.


Q: What happens if I take Sildenafil Medreg and don't have sex?

Sildenafil requires natural sexual stimulation to work. It acts by enhancing the body's natural response to arousal, so taking the medicine alone is generally not expected to cause an erection without sexual stimulation.


Q: Does alcohol reduce the effectiveness of Sildenafil Medreg?

Regulatory documents indicate that caution should be exercised regarding alcohol consumption while using this medicine. Because the medicine can cause a drop in blood pressure, combining it with alcohol may further increase the risk of side effects like dizziness or fainting.


Q: Why are there different strengths of Sildenafil Medreg tablets available?

Different strengths are manufactured to provide options for dosage adjustment based on efficacy and tolerability. This allows the use of specific lower starting doses recommended for certain populations, such as older patients or those with organ impairment.


Q: Does Sildenafil Medreg affect fertility or sperm count?

Studies conducted in healthy male volunteers indicate that Sildenafil does not affect the movement or shape of sperm. No negative effects on fertility have been identified or reported in official prescribing information based on the studies conducted.


Q: Is Sildenafil Medreg a treatment or a temporary fix for ED?

For erectile dysfunction, the medicine is taken 'as needed' before sexual activity. This indicates that the medicine provides an effect for a specific event, as opposed to being a scheduled, long-term therapeutic cure for the underlying cause of ED.


Q: Why does grapefruit juice interact with Sildenafil Medreg?

Grapefruit juice contains substances that inhibit an enzyme in your body, known as CYP3A4, which is responsible for breaking down Sildenafil. Inhibiting this enzyme can cause the level of Sildenafil in your bloodstream to increase, potentially leading to more pronounced side effects.


Q: How long does Sildenafil Medreg stay in your system?

Sildenafil is primarily broken down in the liver and eliminated from the body. Regulatory pharmacokinetic studies indicate that the terminal half-life of the medicine—the time it takes for half of the drug to be eliminated—is approximately 3 to 5 hours.


Q: Can I buy Sildenafil Medreg legally online?

Sildenafil Medreg is classified as a prescription-only medicine. It requires a valid, authorized prescription from a qualified healthcare professional before any pharmacy, including an online pharmacy, can legally dispense it.


Q: Is Sildenafil Medreg addictive?

Official product information does not classify Sildenafil as a controlled substance, nor do regulatory documents list addiction, abuse, or dependence among the known risks or side effects.


Q: Can Sildenafil Medreg be split or crushed?

Sildenafil Medreg is supplied as a film-coated tablet. Official regulatory documentation does not provide instructions for splitting, crushing, or otherwise manipulating the tablet. Therefore, it is generally recommended that the tablet be swallowed whole as supplied.


Q: Why is a medical exam required before starting Sildenafil Medreg?

A medical exam is necessary to evaluate health status, particularly cardiovascular health, to determine if the medicine can be used safely. This is crucial because Sildenafil is contraindicated (should not be used) in patients taking nitrate medicines or those with severe low blood pressure or a recent history of a heart attack or stroke.


Q: Is Sildenafil Medreg used to treat premature ejaculation?

The official therapeutic indications for Sildenafil are limited to the treatment of erectile dysfunction (ED) and Pulmonary Arterial Hypertension (PAH). It is not officially indicated or approved for the treatment of premature ejaculation.

Advertisements

How should Sildenafil Medreg be stored and disposed of?

How to Store and Dispose of Sildenafil Medreg?

Sildenafil Medreg (sildenafil citrate tablets) must be stored according to governmental regulatory requirements to ensure product stability and safety.

Storage Requirements

  • Temperature: Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with excursions permitted up to 30 C (86 F). Do not freeze.
  • Protection: The medicine must be protected from light and moisture and kept in its original container.
  • Child Safety: All tablets must be strictly kept out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired tablets must be conducted in accordance with local regulations as advised by a pharmacist. Medicines should generally not be disposed of via wastewater or household waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Sildenafil Medreg found in:

A-Z Index: